Chesley Taft & Associates LLC Johnson & Johnson Transaction History

Chesley Taft & Associates LLC

  • $2.08 Billion
  • Q3 2024

A detailed history of Chesley Taft & Associates LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 208,840 shares of JNJ stock, worth $32.4 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares
208,840
Previous 210,928 0.99%
Holding current value
$32.4 Million
Previous $30.8 Million 9.78%
% of portfolio
1.63%
Previous 1.56%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
SELL
$145.48 - $167.38 $303,762 - $349,489
-2,088 Reduced 0.99%
208,840 $33.8 Million
Q2 2024

Jul 19, 2024
BUY
$144.38 - $157.78 $342,613 - $374,411
2,373 Added 1.14%
210,928 $30.8 Million
Q1 2024

Apr 15, 2024
BUY
$155.22 - $162.74 $78,696 - $82,509
507 Added 0.24%
208,555 $33 Million
Q4 2023

Jan 11, 2024
SELL
$145.6 - $158.88 $421,220 - $459,639
-2,893 Reduced 1.37%
208,048 $32.6 Million
Q3 2023

Oct 10, 2023
SELL
$155.75 - $174.48 $308,852 - $345,993
-1,983 Reduced 0.93%
210,941 $32.9 Million
Q2 2023

Jul 17, 2023
SELL
$154.35 - $166.11 $1.95 Million - $2.1 Million
-12,640 Reduced 5.6%
212,924 $35.2 Million
Q1 2023

Apr 11, 2023
SELL
$151.05 - $180.26 $169,478 - $202,251
-1,122 Reduced 0.49%
225,564 $35 Million
Q4 2022

Jan 19, 2023
BUY
$160.2 - $179.79 $81,221 - $91,153
507 Added 0.22%
226,686 $0
Q3 2022

Oct 13, 2022
SELL
$161.33 - $179.52 $162,781 - $181,135
-1,009 Reduced 0.44%
226,179 $36.9 Million
Q2 2022

Jul 07, 2022
SELL
$168.19 - $186.01 $89,140 - $98,585
-530 Reduced 0.23%
227,188 $40.3 Million
Q1 2022

Apr 14, 2022
SELL
$158.14 - $179.59 $1.03 Million - $1.17 Million
-6,503 Reduced 2.78%
227,718 $41 Million
Q4 2021

Jan 05, 2022
BUY
$155.93 - $173.01 $378,753 - $420,241
2,429 Added 1.05%
234,221 $40.1 Million
Q3 2021

Oct 05, 2021
SELL
$161.5 - $179.47 $37,468 - $41,637
-232 Reduced 0.1%
231,792 $37.4 Million
Q2 2021

Jul 07, 2021
SELL
$159.48 - $171.07 $262,982 - $282,094
-1,649 Reduced 0.71%
232,024 $38.2 Million
Q1 2021

Apr 06, 2021
BUY
$153.07 - $170.48 $377,929 - $420,915
2,469 Added 1.07%
233,673 $38.2 Million
Q4 2020

Jan 11, 2021
SELL
$137.11 - $157.38 $17,001 - $19,515
-124 Reduced 0.05%
231,204 $36.4 Million
Q3 2020

Oct 08, 2020
BUY
$140.38 - $153.83 $778,687 - $853,295
5,547 Added 2.46%
231,328 $34.4 Million
Q2 2020

Jul 08, 2020
BUY
$128.81 - $155.51 $1.61 Million - $1.94 Million
12,468 Added 5.84%
225,781 $31.8 Million
Q1 2020

Apr 15, 2020
SELL
$111.14 - $153.99 $319,527 - $442,721
-2,875 Reduced 1.33%
213,313 $28 Million
Q4 2019

Jan 10, 2020
BUY
$127.5 - $146.44 $2.17 Million - $2.49 Million
17,029 Added 8.55%
216,188 $31.5 Million
Q3 2019

Oct 07, 2019
SELL
$126.95 - $142.14 $254,661 - $285,132
-2,006 Reduced 1.0%
199,159 $25.8 Million
Q2 2019

Jul 10, 2019
SELL
$131.15 - $144.24 $1,573 - $1,730
-12 Reduced 0.01%
201,165 $28 Million
Q1 2019

Apr 05, 2019
SELL
$125.72 - $139.79 $305,876 - $340,109
-2,433 Reduced 1.19%
201,177 $28.1 Million
Q4 2018

Jan 07, 2019
SELL
$122.84 - $147.84 $14,249 - $17,149
-116 Reduced 0.06%
203,610 $26.3 Million
Q3 2018

Oct 12, 2018
BUY
$121.58 - $142.88 $220,910 - $259,612
1,817 Added 0.9%
203,726 $28.1 Million
Q2 2018

Jul 12, 2018
SELL
$119.4 - $131.76 $492,763 - $543,773
-4,127 Reduced 2.0%
201,909 $24.5 Million
Q1 2018

Apr 11, 2018
BUY
$125.1 - $148.14 $36,404 - $43,108
291 Added 0.14%
206,036 $26.4 Million
Q4 2017

Jan 10, 2018
SELL
$131.22 - $143.62 $138,043 - $151,088
-1,052 Reduced 0.51%
205,745 $28.7 Million
Q3 2017

Oct 13, 2017
BUY
$129.47 - $135.38 $26.8 Million - $28 Million
206,797
206,797 $26.9 Million

Others Institutions Holding JNJ

# of Institutions
4,272
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Chesley Taft & Associates LLC Portfolio

Follow Chesley Taft & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email